Skip to main content

BIO-X Accelerate Make an IMPACT in healthcare and life science

The industry needs to adapt its operations for sustainable development. At the same time the healthcare is facing challenges. These societal challenges, together with the transformation of the industry, require increased digital development, more innovations, and an increased use of digital tools. Therefore, STUNS Life science offers BIO-X Accelerate where companies are given the opportunity to validate their solution in the healthcare and/or the life science industry.

Who can apply?

Small and medium-sized enterprises based (registered seat) in East Middle Sweden.
That includes Uppsala, Västmanland, Södermanland, Östergötland, and Örebro counties.

What can you apply for?

Validation of technical or digital solutions (products/services) that can create IMPACT in healthcare and/or the life science industry.

How much can you apply for?

1–10 MSEK (covering 30% of the costs).
The financing is provided by the European Regional Development Fund and the Swedish Agency for Economic and Regional Growth (Tillväxtverket).

Important dates

Simplified Application

Closed

April 10, 2024

Detailed Application

(For Selected Applicants)

Opens

May 2, 2024

Closes

May 20, 2024

Hearing

June 17 and 18, 2024

Project Period

Companies can initiate their projects earliest after a decision from the Swedish Agency for Economic and Regional Growth (Tillväxtverket), and these projects must conclude by August 31, 2026. The projects can run for up to two years from the decision date.

Mandatory kick-off meeting

June 25, 2024

The BIO-X Accelerate
program offers

Financing
BIO-X Accelerate grants selected companies funding of 30% of actual costs. The project period may be a maximum of 24 months. The applicant must cover the remaining costs themselves. Within the process, an investment meeting will also be held, to increase the companies’ opportunities to pitch their ideas to private investors.

Process support and access to expertise
Projects receive funding, support, and access to expertise via STUNS’ network. Applications will have the opportunity to receive feedback on their applications in the first application round.

Furthermore, the top ranked applicants who makes it to the extended application round will be invited to a pitch meeting with investors. In connection to the investment meeting, the companies that are invited to pitch will receive pitch training through our strategic partner Connect.

The network can also be helpful when contacting potential test environments.

Retained ownership
The company retains full ownership of project results and its data with complete confidentiality.

Increased chances of success
After project completion, the project will significantly have reduced its technical, business and market risks, enabling other future investments and/or market introduction.

With support from an Advisory Board (selected experts), access to a large network and programs and activities offered during the project period, you have higher chances for a successful implementation of the project.

The application for this call have closed and the applications in the first step are under review. 

null
Call text
Read the full call text (sv/eng)
Download here
null
FAQ
Still questions after reading the call text?
Read FAQ (sv/eng)
null
Questions?
Do not hesitate to get in touch!
Contact us
Financing: STUNS Life science, The European Regional Development Fund (ERDF)/ Tillväxtverket
STUNS Life science role: Project Manager
Contact: Dajana Ilic Susak, Malin Wiederholm, Anisha Khan and Björn Arvidsson

Funded by

Strategic partners

Supporting partners

stunsls rätt